LFCR
Lifecore Biomedical Inc.
NASDAQ: LFCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.07
+2.63% today
Updated 2026-04-30
Market cap
$190.38M
P/E ratio
—
P/S ratio
1.47x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $9
Volume
0.4M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+3.0
Profitability
D3.0
Valuation
D—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$6.50
+28.21%
12-Month target
—
—
Intrinsic (DCF)
$5.87
Margin of safety
-23.17%
1 Strong Buy2 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $3.61M — positive
Risks
- Thin margins at -23.80%
- Revenue declining -3.80% QoQ
- 23.17% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $185.79M | $111.27M | $128.26M | $128.87M | $129.47M |
| Net income | $-97.43M | $-116.72M | $12.01M | $-38.72M | $-7.97M |
| EPS | — | — | — | — | $-1.27 |
| Free cash flow | $-52.53M | $-52.53M | $-18.14M | $-13.62M | $3.61M |
| Profit margin | -52.44% | -104.89% | 9.37% | -30.04% | -23.80% |
Peer comparison
Smart narrative
Lifecore Biomedical Inc. trades at $5.07. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $129.47M. with profit margins at -23.80%. Our DCF model estimates intrinsic value at $5.87.
Frequently asked questions
What is Lifecore Biomedical Inc.'s stock price?
Lifecore Biomedical Inc. (LFCR) trades at $5.07.
Is Lifecore Biomedical Inc. overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell). DCF value $5.87.
What is the price target of Lifecore Biomedical Inc. (LFCR)?
The analyst target price is $6.50, representing +28.2% upside from the current price of $5.07.
What is the intrinsic value of Lifecore Biomedical Inc. (LFCR)?
Based on our DCF model, intrinsic value is $5.87, a -23.2% margin of safety versus $5.07.
What is Lifecore Biomedical Inc.'s revenue?
TTM revenue is $129.47M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.47x
ROE-76.40%
Beta0.88
50D MA$5.52
200D MA$7.04
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—